APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal AI-assisted Diagnosis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gastrointestinal AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026

6 March 2026195 pages

Choose your research edition.

Industry ResearchGastrointestinal AI-assisted Diagnosis Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal AI-assisted Diagnosis Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Gastrointestinal AI-assisted Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal AI-assisted Diagnosis Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Gastrointestinal AI-assisted Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gastrointestinal AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gastrointestinal AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastrointestinal AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gastrointestinal AI-assisted Diagnosis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gastrointestinal AI-assisted Diagnosis market include Wision, Sense Time, Xiamen inno Medical, Tianjin Yujin artificial intelligence Medical, Surgi-plan, Intelligent Scopes Corp, RSIP Vision and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Gastrointestinal AI-assisted Diagnosis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gastrointestinal AI-assisted Diagnosis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gastrointestinal AI-assisted Diagnosis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Gastrointestinal AI-assisted Diagnosis market.

Gastrointestinal AI-assisted Diagnosis Segment by Company

Wision

Sense Time

Xiamen inno Medical

Tianjin Yujin artificial intelligence Medical

Surgi-plan

Intelligent Scopes Corp

RSIP Vision

Medtronic

Gastrointestinal AI-assisted Diagnosis Segment by Type

Cloud-based

On-Primes

Gastrointestinal AI-assisted Diagnosis Segment by Application

Hospital

Clinic

Imaging Center

Gastrointestinal AI-assisted Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gastrointestinal AI-assisted Diagnosis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Gastrointestinal AI-assisted Diagnosis key companies, revenue, market share, and recent developments.

3. To split the Gastrointestinal AI-assisted Diagnosis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Gastrointestinal AI-assisted Diagnosis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gastrointestinal AI-assisted Diagnosis significant trends, drivers, influence factors in global and regions.

6. To analyze Gastrointestinal AI-assisted Diagnosis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal AI-assisted Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal AI-assisted Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal AI-assisted Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gastrointestinal AI-assisted Diagnosis industry.

Chapter 3: Detailed analysis of Gastrointestinal AI-assisted Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Gastrointestinal AI-assisted Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Gastrointestinal AI-assisted Diagnosis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gastrointestinal AI-assisted Diagnosis Industry Trends Table 2. Gastrointestinal AI-assisted Diagnosis Industry Drivers Table 3. Gastrointestinal AI-assisted Diagnosis Industry Opportunities and Challenges Table 4. Gastrointestinal AI-assisted Diagnosis Industry Restraints Table 5. Global Gastrointestinal AI-assisted Diagnosis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gastrointestinal AI-assisted Diagnosis Revenue Share by Company (2021-2026) Table 7. Global Gastrointestinal AI-assisted Diagnosis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Gastrointestinal AI-assisted Diagnosis Key Company Manufacturing Base & Headquarters Table 9. Global Gastrointestinal AI-assisted Diagnosis Company, Product Type & Application Table 10. Global Gastrointestinal AI-assisted Diagnosis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Gastrointestinal AI-assisted Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On-Primes Table 16. Global Gastrointestinal AI-assisted Diagnosis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Gastrointestinal AI-assisted Diagnosis Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Gastrointestinal AI-assisted Diagnosis Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type (2021-2026) Table 20. Global Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Imaging Center Table 24. Global Gastrointestinal AI-assisted Diagnosis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Gastrointestinal AI-assisted Diagnosis Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Gastrointestinal AI-assisted Diagnosis Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application (2021-2026) Table 28. Global Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application (2027-2032) Table 29. Global Gastrointestinal AI-assisted Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Gastrointestinal AI-assisted Diagnosis Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Gastrointestinal AI-assisted Diagnosis Sales Value Share by Region (2021-2026) Table 32. Global Gastrointestinal AI-assisted Diagnosis Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Gastrointestinal AI-assisted Diagnosis Sales Value Share by Region (2027-2032) Table 34. Global Gastrointestinal AI-assisted Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Gastrointestinal AI-assisted Diagnosis Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Gastrointestinal AI-assisted Diagnosis Sales Value Market Share by Country (2021-2026) Table 37. Global Gastrointestinal AI-assisted Diagnosis Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Gastrointestinal AI-assisted Diagnosis Sales Value Market Share by Country (2027-2032) Table 39. Wision Company Information Table 40. Wision Business Overview Table 41. Wision Gastrointestinal AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Wision Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 43. Wision Recent Development Table 44. Sense Time Company Information Table 45. Sense Time Business Overview Table 46. Sense Time Gastrointestinal AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Sense Time Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 48. Sense Time Recent Development Table 49. Xiamen inno Medical Company Information Table 50. Xiamen inno Medical Business Overview Table 51. Xiamen inno Medical Gastrointestinal AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Xiamen inno Medical Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 53. Xiamen inno Medical Recent Development Table 54. Tianjin Yujin artificial intelligence Medical Company Information Table 55. Tianjin Yujin artificial intelligence Medical Business Overview Table 56. Tianjin Yujin artificial intelligence Medical Gastrointestinal AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Tianjin Yujin artificial intelligence Medical Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 58. Tianjin Yujin artificial intelligence Medical Recent Development Table 59. Surgi-plan Company Information Table 60. Surgi-plan Business Overview Table 61. Surgi-plan Gastrointestinal AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Surgi-plan Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 63. Surgi-plan Recent Development Table 64. Intelligent Scopes Corp Company Information Table 65. Intelligent Scopes Corp Business Overview Table 66. Intelligent Scopes Corp Gastrointestinal AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Intelligent Scopes Corp Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 68. Intelligent Scopes Corp Recent Development Table 69. RSIP Vision Company Information Table 70. RSIP Vision Business Overview Table 71. RSIP Vision Gastrointestinal AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. RSIP Vision Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 73. RSIP Vision Recent Development Table 74. Medtronic Company Information Table 75. Medtronic Business Overview Table 76. Medtronic Gastrointestinal AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Medtronic Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 78. Medtronic Recent Development Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Gastrointestinal AI-assisted Diagnosis Product Image Figure 2. Global Gastrointestinal AI-assisted Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastrointestinal AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastrointestinal AI-assisted Diagnosis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On-Primes Image Figure 9. Global Gastrointestinal AI-assisted Diagnosis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Gastrointestinal AI-assisted Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Imaging Center Image Figure 15. Global Gastrointestinal AI-assisted Diagnosis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Gastrointestinal AI-assisted Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application (2021-2032) Figure 18. Global Gastrointestinal AI-assisted Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Gastrointestinal AI-assisted Diagnosis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Gastrointestinal AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 21. North America Gastrointestinal AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Gastrointestinal AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Gastrointestinal AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Gastrointestinal AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Gastrointestinal AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Gastrointestinal AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 27. South America Gastrointestinal AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Gastrointestinal AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Gastrointestinal AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Wision
  • Sense Time
  • Xiamen inno Medical
  • Tianjin Yujin artificial intelligence Medical
  • Surgi-plan
  • Intelligent Scopes Corp
  • RSIP Vision
  • Medtronic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gastrointestinal AI-assisted Diagnosis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gastrointestinal AI-assisted Diagnosis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Gastrointestinal AI-assisted Diagnosis Market Dynamics
  1. 2.1 Gastrointestinal AI-assisted Diagnosis Industry Trends
  2. 2.2 Gastrointestinal AI-assisted Diagnosis Industry Drivers
  3. 2.3 Gastrointestinal AI-assisted Diagnosis Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal AI-assisted Diagnosis Industry Restraints
3 Gastrointestinal AI-assisted Diagnosis Market by Company
  1. 3.1 Global Gastrointestinal AI-assisted Diagnosis Company Revenue Ranking in 2025
  2. 3.2 Global Gastrointestinal AI-assisted Diagnosis Revenue by Company (2021-2026)
  3. 3.3 Global Gastrointestinal AI-assisted Diagnosis Company Ranking (2024-2026)
  4. 3.4 Global Gastrointestinal AI-assisted Diagnosis Company Manufacturing Base and Headquarters
  5. 3.5 Global Gastrointestinal AI-assisted Diagnosis Company Product Type and Application
  6. 3.6 Global Gastrointestinal AI-assisted Diagnosis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Gastrointestinal AI-assisted Diagnosis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Gastrointestinal AI-assisted Diagnosis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Gastrointestinal AI-assisted Diagnosis Market by Type
  1. 4.1 Gastrointestinal AI-assisted Diagnosis Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On-Primes
  4. 4.2 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Type
  5. 4.2.1 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Type (2021-2032)
  7. 4.2.3 Global Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type (2021-2032)
5 Gastrointestinal AI-assisted Diagnosis Market by Application
  1. 5.1 Gastrointestinal AI-assisted Diagnosis Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Imaging Center
  5. 5.2 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Application
  6. 5.2.1 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Application (2021-2032)
  8. 5.2.3 Global Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application (2021-2032)
6 Gastrointestinal AI-assisted Diagnosis Regional Value Analysis
  1. 6.1 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gastrointestinal AI-assisted Diagnosis Sales Value (2021-2032)
  7. 6.3.2 North America Gastrointestinal AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Gastrointestinal AI-assisted Diagnosis Sales Value (2021-2032)
  10. 6.4.2 Europe Gastrointestinal AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Gastrointestinal AI-assisted Diagnosis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Gastrointestinal AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Gastrointestinal AI-assisted Diagnosis Sales Value (2021-2032)
  16. 6.6.2 South America Gastrointestinal AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Gastrointestinal AI-assisted Diagnosis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Gastrointestinal AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
7 Gastrointestinal AI-assisted Diagnosis Country-level Value Analysis
  1. 7.1 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Gastrointestinal AI-assisted Diagnosis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Gastrointestinal AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Gastrointestinal AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Gastrointestinal AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wision
  2. 8.1.1 Wision Company Information
  3. 8.1.2 Wision Business Overview
  4. 8.1.3 Wision Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wision Gastrointestinal AI-assisted Diagnosis Product Portfolio
  6. 8.1.5 Wision Recent Developments
  7. 8.2 Sense Time
  8. 8.2.1 Sense Time Company Information
  9. 8.2.2 Sense Time Business Overview
  10. 8.2.3 Sense Time Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sense Time Gastrointestinal AI-assisted Diagnosis Product Portfolio
  12. 8.2.5 Sense Time Recent Developments
  13. 8.3 Xiamen inno Medical
  14. 8.3.1 Xiamen inno Medical Company Information
  15. 8.3.2 Xiamen inno Medical Business Overview
  16. 8.3.3 Xiamen inno Medical Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Xiamen inno Medical Gastrointestinal AI-assisted Diagnosis Product Portfolio
  18. 8.3.5 Xiamen inno Medical Recent Developments
  19. 8.4 Tianjin Yujin artificial intelligence Medical
  20. 8.4.1 Tianjin Yujin artificial intelligence Medical Company Information
  21. 8.4.2 Tianjin Yujin artificial intelligence Medical Business Overview
  22. 8.4.3 Tianjin Yujin artificial intelligence Medical Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tianjin Yujin artificial intelligence Medical Gastrointestinal AI-assisted Diagnosis Product Portfolio
  24. 8.4.5 Tianjin Yujin artificial intelligence Medical Recent Developments
  25. 8.5 Surgi-plan
  26. 8.5.1 Surgi-plan Company Information
  27. 8.5.2 Surgi-plan Business Overview
  28. 8.5.3 Surgi-plan Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Surgi-plan Gastrointestinal AI-assisted Diagnosis Product Portfolio
  30. 8.5.5 Surgi-plan Recent Developments
  31. 8.6 Intelligent Scopes Corp
  32. 8.6.1 Intelligent Scopes Corp Company Information
  33. 8.6.2 Intelligent Scopes Corp Business Overview
  34. 8.6.3 Intelligent Scopes Corp Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Intelligent Scopes Corp Gastrointestinal AI-assisted Diagnosis Product Portfolio
  36. 8.6.5 Intelligent Scopes Corp Recent Developments
  37. 8.7 RSIP Vision
  38. 8.7.1 RSIP Vision Company Information
  39. 8.7.2 RSIP Vision Business Overview
  40. 8.7.3 RSIP Vision Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 RSIP Vision Gastrointestinal AI-assisted Diagnosis Product Portfolio
  42. 8.7.5 RSIP Vision Recent Developments
  43. 8.8 Medtronic
  44. 8.8.1 Medtronic Company Information
  45. 8.8.2 Medtronic Business Overview
  46. 8.8.3 Medtronic Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Medtronic Gastrointestinal AI-assisted Diagnosis Product Portfolio
  48. 8.8.5 Medtronic Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst